On September 1, Intel fell 3.01% in pre-market trading, trading at $86.82 per share, with turnover of approximately $97.55 million. The decline was driven by persistent investor concerns over the dilutive impact of the company's upsized $20 billion common stock offering.

Intel recently priced approximately 210.5 million new shares at $95 each, raising the offering size from an original $15 billion target to roughly $20 billion to fund manufacturing expansion and general corporate purposes. Analysts estimate the issuance will result in approximately 4% to 5% earnings-per-share dilution for existing shareholders. With the current stock price now trading more than 5% below the $95 offering price, market sentiment has turned increasingly cautious as supply pressure from the new shares weighs on valuation.

Despite several positive developments — including SK Hynix evaluating Intel as a foundry partner for HBM4E base die production and reports that Intel's 14A process defect density reached its best level since the 22nm node — short-term trading activity remains focused on the offering overhang. Options market activity in recent sessions has also reflected a cautious-to-bearish tone, with notable bearish call spreads and put purchases reinforcing the near-term risk-off positioning.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)